Scientists are rapidly focused on retatrutide, a novel medication created by Eli Lilly, as a possible breakthrough in physique reduction . Unlike many earlier approaches, retatrutide is a double -action receptor targeting equally GLP-1 and GIP, chemicals that influence hunger and blood sugar contro